The global antiemetics drugs market size reached at USD 7.25 billion in 2024 and is predicted to increase from USD 8.37 billion in 2025 to reach nearly USD 30.63 billion by 2034, expanding at a CAGR of 15.5% from 2025 to 2034, Study Published by Vision Research Reports.
The market’s impressive growth is driven by the rising prevalence of cancer worldwide, increasing use of chemotherapy and radiation therapies, and a growing incidence of gastrointestinal disorders, motion sickness, and postoperative nausea.
Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.
Preview the Report Before You Buy – Get Sample Pages 👉
https://www.visionresearchreports.com/report/sample/41038
What are Antiemetic Drugs?
Antiemetic drugs are medications that help to prevent and treat nausea and vomiting. There are several types of antiemetics. Some of these types are available over the counter (OTC) and others require prescriptions. Since there can be several different causes of nausea and vomiting, certain types of antiemetics are more effective for specific causes. The antiemetics drugs market is a vital segment within the pharmaceutical industry and is focused on addressing the challenges of nausea and vomiting as well as prevalent symptoms associated with various medical conditions and treatments.
The market is experiencing robust growth due to the increasing global prevalence of nausea and vomiting conditions related to chemotherapy, pregnancy and other gastrointestinal disorders. With a growing aging population and rising cancer cases, the demand for effective antiemetic solutions is expected to climb up even more, driving the market forward.
Antiemetic Drugs Market Key Highlights:
• By region, North America led the market with the largest market share in 2024.
• By region, Asia Pacific market is expected to grow at the notable CAGR from 2025 to 2034.
• By drug type, the serotonin-receptor antagonists segment contributed the largest market share in 2024.
• By application, the chemotherapy segment registered the maximum market share in 2024.
• By application, the postoperative surgery segment is estimated to expand the fastest CAGR during the forecast period.
• By end-use, the retail pharmacies segment generated the maximum market share in 2024.
What are the Key Growth Drivers of the Antiemetic Drugs Market?
The antiemetic drugs market is currently experiencing significant transformations. These changes are driven by various factors such as the increasing prevalence of nausea and vomiting associated with various medical conditions, including chemotherapy and postoperative recovery. This has led to a rise in demand for effective antiemetic therapies. Additionally, advancements in drug formulations and delivery methods are also helping in enhancing patient compliance and therapeutic outcomes.
The market dynamic is also influenced due to the growing awareness about the importance of managing nausea in both clinical as well as outpatient settings. This awareness creates competition within various market players and fosters innovation in the pharmaceutical domain. Moreover, the market is also is witnessing a shift towards personalized medicine, where treatments can be tailored to individual patient profiles. All these factors contribute to the market’s expanding landscape.
What are the Major Trends in the Antiemetic Drugs Market?
• Advancements in Drug Formulations: The market is witnessing a trend towards the development of novel drug formulations and delivery methods in the antiemetics market. Pharmaceutical companies are actively creating long-acting formulations, transdermal patches and sublingual tablets that can improve convenience, patient compliance and prolonged efficacy.
• Expansion in Indications: Antiemetics are increasingly being studied on and approved for new indications beyond chemotherapy-induced nausea and vomiting. There is growing trend of using antiemetics for managing nausea and vomiting, especially associated with conditions like motion sickness, pregnancy, post-operative recovery and gastroenteritis.
• Combination Therapies: Combination therapies are gaining traction in the market as they are aimed at achieving synergistic effects in controlling nausea and vomiting, particularly in patients who undergo highly aggressive chemotherapy.
• Personalized Medicines: The market has also witnessed a rise in personalized medicine, driven by advancements in genetic research and pharmacogenomics. This can help can optimize therapeutic outcomes and also minimize adverse effects.
Discover the Full Market Insights 👉
https://www.visionresearchreports.com/antiemetics-drugs-market/41038
Antiemetic Drugs Market Challenges
What are the Major Challenges in the Market?
The antiemetic drugs market does face its fair share of challenges that could hinder its growth and development. One of the primary challenges faced by the market is the chances of adverse effects that are associated with some antiemetic drugs. Skepticism among consumers could limit their use, especially in sensitive populations such as pregnant women and the elderly.
Additionally, the market’s regulatory landscape can be quite complex, with stringent approval processes and different requirements across different regions. Navigating these regulatory hurdles can be challenging for small scale pharmaceutical companies or startups who are looking to introduce new antiemetic products, thus slowing down market entry.
Antiemetic Drugs Market Opportunities
What are the Key Opportunities in the Market?
Technological advancements and innovations in drug delivery systems are opening up new avenues of opportunities in the market. The development of novel drug formulations such as transdermal patches and orally disintegrating tablets is making it easier and convenient for patients to follow their treatment plans. These innovative solutions are especially beneficial for sensitive populations like the elderly or for those who have difficulty in swallowing pills. These various formats help to broaden consumer base. Moreover, the introduction of new molecules with better efficacy profiles and minimal side effects is anticipated to driving market growth even more in the upcoming years.
Another such key opportunity is the market’s potential for expanding applications beyond traditional uses. As scientific understandings of nausea and vomiting continue to evolve, new applications for antiemetic drugs are being actively explored. This includes use in the migraines and vestibular disorders, where nausea can be common symptom. Additionally, the integration of antiemetic drugs into personalized medicine could drive future growth and boost market potential.
Antiemetic Drugs Market Report Coverage
|
Report Attribute |
Key Statistics |
|
Market Size in 2025 |
USD 8.37 Billion |
|
Market Size in 2026 |
USD 9.67 Billion |
|
Market Size in 2030 |
USD 17.21 Billion |
|
Market Size in 2032 |
USD 22.96 Billion |
|
Market Size by 2034 |
USD 30.63 Billion |
|
Growth rate from 2025 to 2034 |
CAGR of 15.5% |
|
Base Year |
2024 |
|
Forecast Period |
2025 to 2034 |
|
Segments Covered |
By Drug Type, By Application, By End-use |
|
Companies Covered |
Pfizer Inc., Cipla Inc., Merck KGaA, Eagle Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., GSK plc, Astellas Pharma Inc., Glenmark Pharmaceuticals Ltd., Viatris Inc., and Baxter. |
For Orders or Inquiries, Don’t Hesitate to Reach Out: sales@visionresearchreports.com
Antiemetic Drugs Regional Analysis
Why is North America Dominating the market?
North America dominated the market in 2024, driven by a combination of factors such as a high incidence of cancer cases, advanced healthcare infrastructure, and substantial investment in drug development. The region benefits from a strong, pre-established pharmaceutical industry which has a strong emphasis on research and innovation. The market is also supported by the ongoing development of new drug formulations and the increasing adoption of combination therapies in clinical practice.
What are the Advancements in Asia-Pacific?
Asia Pacific is expected This growth is driven by several factors, including the region’s increasing healthcare expenditure, a rapidly rising population and a growing awareness of gastrointestinal and cancer-related conditions. The region has also witnessed an expansion of healthcare services in rural and underdeveloped areas, which contributes to the market's growth potential even more.
Need a Tailored Version of the Report? | Get Customization Options Here:
https://www.visionresearchreports.com/report/customization/41038
Antiemetic Drugs Segmental Analysis
Drug Type Analysis
Which Drug Type Dominated the Market in 2024?
The serotonin-receptor antagonists segment dominated the market in 2024. This dominance can be attributed to the increasing utilization of serotonin-receptor antagonist drugs to mitigate nausea and vomiting associated with chemotherapy, radiation therapy and anesthesia. This trend is further accentuated by the escalating global incidence of cancer cases. The advantage of this segment lies in its ability to provide rapid relief with minimal side effects, which is crucial in maintaining patient comfort during aggressive cancer treatments.
The dopamine receptor antagonist drugs segment is expected to grow at the fastest rate throughout the forecast period. This growth is attributed to the mounting approvals received by these drugs from regulatory authorities. These antagonists are versatile in application and are used to treat a variety of nausea-inducing conditions, including motion sickness and gastrointestinal disorders.
Application Analysis
Which Application Led the Market as of this Year?
The chemotherapy segment led the market as of this year. This is due to the increasing utilization of antiemetic drugs for managing nausea and vomiting associated with chemotherapy coupled with a surge in product launches within this domain. As cancer therapies evolve and become more potent, the demand for new and more effective antiemetic solutions continues to rise. Effective control over such symptoms is a priority as it can significantly enhance patient compliance and their quality of life.
The postoperative surgery segment is estimated to exhibit the fastest growth rate during the forecast years. This growth is fueled by the growing adoption of antiemetic drugs to mitigate postoperative vomiting and nausea. Additionally, the prevalence of adverse effects, such as nausea and vomiting due to anesthesia is expected to contribute to this segment’s growth even more.
End-use Analysis
Which End User Held the Largest Market Share in 2024?
The retail pharmacies segment held the largest market share in 2024. This dominance is fueled by the convenience and product availability offered by retail pharmacies. Additionally, the widespread presence of key retail pharmacy chains on a global scale is expected to drive the demand for these medications even more. Their convenience and easy accessibility make them a popular choice for individuals who are seeking quick relief.
The others segment, which includes online platforms or e-commerce is anticipated to exhibit the fastest rate of growth over the forecast period. This is due to the increasing penetration of smartphones and the internet worldwide, a growing awareness of online pharmacies and the industry's increasing emphasis on strengthening their online distribution networks. The convenience of ordering medications online along with the ability to compare prices and access a wide range of products has contributed to the segment’s growing popularity.
Browse More Insights:
• U.S. Antibody Drug Conjugates Market: https://www.visionresearchreports.com/us-antibody-drug-conjugates-market/41773
• Local Anesthesia Drugs Market: https://www.visionresearchreports.com/local-anesthesia-drugs-market/41721
• U.S. Ultomiris Drug Market: https://www.visionresearchreports.com/us-ultomiris-drug-market/41720
• Ultomiris Drug Market: https://www.visionresearchreports.com/ultomiris-drug-market/41718
• Antifungal Drugs Market: https://www.visionresearchreports.com/antifungal-drugs-market/41717
• Contraceptive Drugs and Devices Market: https://www.visionresearchreports.com/contraceptive-drugs-and-devices-market/41596
• Generic Drugs Market: https://www.visionresearchreports.com/generic-drugs-market/41283
• Antibody Drug Conjugates Market: https://www.visionresearchreports.com/antibody-drug-conjugates-market/41295
• U.S. Generic Drugs Market: https://www.visionresearchreports.com/us-generic-drugs-market/41282
Recent Developments in the Antiemetic Drugs Market
• In October 2025, Sunshine Biopharma Inc., which is a leading pharmaceutical company focused on innovative and affordable healthcare solutions, announced that its wholly owned subsidiary, Nora Pharma Inc., has received approval from Health Canada, the Canadian equivalent to the FDA, for the commercialization of Domperidone, a prescription medication used to relieve nausea and vomiting and to enhance gastrointestinal motility. (Source: https://finance.yahoo.com)
• In November 2025, WAT Medical Enterprise Ltd. proudly announced the publication of a groundbreaking clinical trial which demonstrates the significant benefits of the EmeTerm wristband in reducing postoperative nausea and vomiting (PONV) in patients undergoing total hip or knee arthroplasty (THA/TKA) under spinal anesthesia. The combined use of the EmeTerm wristband and antiemetics significantly reduced PONV occurrence and improved overall recovery quality. (Source: https://www.taiwannews.com)
Top Key Players in the Antiemetic Drugs Market
• Pfizer Inc.
• Cipla Inc.
• Merck KGaA
• Eagle Pharmaceuticals, Inc.
• Johnson & Johnson Services, Inc.
• GSK plc.
• Astellas Pharma Inc.
• GLENMARK PHARMACEUTICALS LTD.
• Viatris Inc.
• Baxter
Antiemetic Drugs Market Segmentation
By Drug Type
• Serotonin-receptor Antagonists
• Anticholinergics
• Dopamine Receptor Antagonists
• Neurokinin Receptor Antagonists
• Others (Antihistamines, Cannabinoids)
By Application
• Chemotherapy
• Gastroenteritis
• Post Operative Surgery
• Others
By End-use
• Hospital & Clinics
• Retail Pharmacy
• Others
By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)
Instant Delivery Available | Purchase This Exclusive Research Report Now:
https://www.visionresearchreports.com/report/checkout/41038
You can place an order or ask any questions, please feel free to contact
at: sales@visionresearchreports.com
About Us
Vision Research Reports is a premier service provider offering strategic market insights and solutions that go beyond traditional surveys. We specialize in actionable market research, delivering in-depth qualitative insights and strategies to global industry leaders and executives, helping them navigate future uncertainties. Our offerings include consulting services, syndicated market studies, and bespoke research reports.
We are committed to excellence in qualitative market research, fostering a team of experts with deep industry knowledge. Our goal is to help clients understand both current and future market trends, empowering them to expand their portfolios and achieve their business objectives with the right guidance.
Web: https://www.visionresearchreports.com
Our Trusted Data Partners
Precedence Research | Statifacts | Nova One Advisor
For Latest Update Follow Us: LinkedIn
